The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response
Open accessAbstract
INTRODUCTION: Mild cognitive impairment following chemotherapy is one of the most commonly reported post treatment symptoms by breast cancer survivors. This deterioration in cognitive function, commonly referred to as "chemobrain" or "chemofog," was largely unacknowledged by the medical community until recent years. Although chemobrain has now become the subject of more vigorous exploration, little is known about this specific phenomenon's psychosocial impact on breast cancer survivors. This research documents in-depth the effects that cognitive impairment has on women's personal and professional lives, and our data suggest that greater attention needs to be focused on this arena of survivorship. METHODS: The results are based on an in-depth qualitative study of 74 white and African American breast cancer survivors in California who experience post-treatment side effects. The data reported herein were obtained through the use of focus groups and in-depth interviews. RESULTS: Our data indicate that cognitive impairment can be problematic for survivors, with many asserting that it is their most troublesome post treatment symptom. Survivors report diminished quality of life and daily functioning as a result of chemobrain. Respondents detail a range of coping strategies that they are forced to employ in order to manage their social and professional lives. DISCUSSIONS/CONCLUSIONS: Chemobrain significantly impairs a proportion of cancer survivors, at great cost to them economically, emotionally, and interpersonally. This suggests that more research needs to be conducted on the psychosocial ramifications of post treatment symptoms in order to inform the efforts of the medical and mental health communities as well as the support networks of survivors. IMPLICATIONS FOR CANCER SURVIVORS: A better and broader understanding of the effects of cognitive impairment both in the medical community and among lay people could pave the way for improved social and psychological services for this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crabtree, B. F., Miller, W. L., & Swenson, M. M. (1995) · Nursing Research · doi:10.1097/00006199-199507000-00011 · Cited by 956
Cited by
Duijts, S. F. A., van Egmond, M. P., Spelten, E., van Muijen, P., Anema, J. R., & van der Beek, A. J. (2014) · Psycho-Oncology · doi:10.1002/pon.3467 · Cited by 356
Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy
Christie, L.-A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2000 · Cited by 311
Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors
Kesler, S., Hadi Hosseini, S. M., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., & Morrow, G. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.02.004 · Cited by 300
“Exclusion criteria included (1) previous chemotherapy treatment; (2) major sensory deficit (eg, blindness); (3) color blindness, because some of the training tasks and cognitive tests relied on color; (4) neurologic or major medical conditions known to affect cognitive function; (5) history of inpatient psychiatric ho…”
BackgroundPsychological Aspects to Consider in Breast Cancer Diagnosis and Treatment
Dinapoli, L., Colloca, G., Di Capua, B., & Valentini, V. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01049-3 · Cited by 223
Bray, V. J., Dhillon, H. M., Bell, M. L., Kabourakis, M., Fiero, M. H., Yip, D., Boyle, F., Price, M. A., & Vardy, J. L. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.8201 · Cited by 182
Metadata
- Authors
- Boykoff, N., Moieni, M., & Subramanian, S. K.
- Venue
- Journal of Cancer Survivorship
- Published
- 2009-09-16
- Volume
- 3
- Issue
- 4
- Pages
- 223-32
- ISSN
- 1932-2259 (ISSN-L)
- 1932-2267
- OpenAlex
- W2130390212
- Cited by
- 519
- References
- 1
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. https://app.cochat.ai/papers/10.1007/s11764-009-0098-x
- The paper
- Boykoff, N., Moieni, M., & Subramanian, S. K. (2009). Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-009-0098-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.